Dr CK Narayan recommended to keep stop loss at Rs 1280.
Ajanta Pharma Ltd., incorporated in 1979, is a mid-cap company with a market cap of Rs 11147.04 crore.
Ajanta Pharma Ltd. key products/revenue segments include pharmaceutical products which contributed Rs 1753.68 crore to sales value (96.21 % of total sales), Export incentives which contributed Rs 66.83 crore to sales value (3.66 % of total sales) and other operating revenue which contributed Rs 2.20 Crore to sales value (0.12 % of total sales) for the year ending 31-Mar-2017.
The company has reported net profit after tax of Rs 94.49 crore in the latest quarter.
The company’s top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar Dalal, Mr.Purushottam B Agrawal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal. Company has Kapoor & Parekh Associates as its auditoRs As on 31-03-2018, the company has a total of 88,014,500 shares outstanding.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price